Skeletal muscle-derived cell cultures as potent models in regenerative medicine research

Muscle and Nerve

Volumn 47, Issue 4, 2013, Pages 477-482

  Kelc, Robi ^a   Trapecar, Martin ^b   Vogrin, Matjaz ^a   Cencic, Avrelija ^b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Cell culture; Experimental model; in vitro; in vivo; Skeletal muscle cell

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GAMMA INTERFERON; NONSTEROID ANTIINFLAMMATORY AGENT; SURAMIN; TRANSFORMING GROWTH FACTOR BETA;

CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; GENOMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REGENERATIVE MEDICINE; REVIEW; SKELETAL MUSCLE; SKELETAL MUSCLE DERIVED CELL CULTURE;

ANIMALS; CELLS, CULTURED; HUMANS; MODELS, BIOLOGICAL; MUSCLE FIBERS, SKELETAL; MYOBLASTS, SKELETAL; REGENERATION; REGENERATIVE MEDICINE;

EID: 84875625840     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23688     Document Type: Review

References (54)

1. Guillouzo A, Guguen-Guillouzo C. Evolving concepts in liver tissue modeling and implications for in vitro toxicology. Expert Opin Drug Met 2008;4:1279-1294.
2. Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 2011;85:367-485.
3. Harrison RG, Greenman MJ, Mall FP, Jackson CM. Observations of the living developing nerve fiber. Anat Rec 1907;1:116-128.
4. Earle WR. The mouse fibroblast cultures and changes seen in the living cells. J Nat Cancer Inst 1943;4:165-212.
5. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol 2005;59:587-635.
6. Freshney RI. Culture of animal cells. A manual of basic technique and specialized applications. Hoboken, NJ: Wiley-Blackwell; 2010.
7. Khetani SR, Bhatia SN. Engineering tissues for in vitro applications. Curr Opin Biotechnol 2006;17:524-531.
8. Li N, Tourovskaia A, Folch A. Biology on a chip: microfabrication for studying the behavior of cultured cells. Crit Rev Biomed Eng 2003;31:423-488.
9. Partridge T. Tissue culture of skeletal muscle. In: Pollard J, Walker J, Editors. Basic Cell Culture Protocols, 2nd Ed. Humana Press, 1997.
10. 2+ ions human malignant hyperthermia-susceptible sarcoplasmic reticulum. Biochem Pharmacol 2001;61:1479-1485.
11. El Oakley RM, Ooi OC, Bongso A, Yacoub MH. Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg 2001;71:1724-1733.
12. Slentz DH, Truskey GA, Kraus WE. Effects of chronic exposure to simulated microgravity on skeletal muscle cell proliferation and differentiation. In Vitro Cell Dev Anim 2001;37:148-156.
13. Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, Holman GD, et al. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 2003;60:991-998.
14. Virkamaki A, Ueki K, Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999;103:931-943.
15. Tripathi AK, Ramani UV, Rank DN, Joshi CG. In vitro expression profiling of myostatin, follistatin, decorin and muscle-specific transcription factors in adult caprine contractile myotubes. J Muscle Res Cell M 2011;32:23-30.
16. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA. MyoD is required for myogenic stem cell function in adult skeletal muscle. Gene Dev 1996;10:1173-1183.
17. Liu YB, Chu A, Chakroun I, Islam U, Blais A. Cooperation between myogenic regulatory factors and SIX family transcription factors is important for myoblast differentiation. Nucl Acids Res 2010;38:6857-6871.
18. Kaji H, Ishibashi T, Nagamine K, Kanzaki M, Nishizawa M. Electrically induced contraction of C2C12 myotubes cultured on a porous membrane-based substrate with muscle tissue-like stiffness. Biomaterials 2010;31:6981-6986.
19. Lambernd S, Taube A, Schober A, Platzbecker B, Gorgens SW, Schlich R, et al. Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways. Diabetologia 2012;55:1128-1139.
20. Nedachi T, Fujita H, Kanzaki M. Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle. Am J Physiol Endocrinol M 2008;295:E1191-E1204.
21. Passey S, Martin N, Player D, Lewis MP. Stretching skeletal muscle in vitro: does it replicate in vivo physiology? Biotechnol Lett 2011;33:1513-1521.
22. Hornberger TA, Armstrong DD, Koh TJ, Burkholder TJ, Esser KA. Intracellular signaling specificity in response to uniaxial vs. multiaxial stretch: implications for mechanotransduction. Am J Physiol Cell Physiol 2005;288:C185-194.
23. Hubatsch DA, Jasmin BJ. Mechanical stimulation increases expression of acetylcholinesterase in cultured myotubes. Am J Physiol Cell Physiol 1997;273:C2002-C2009.
24. 2+-dependent mechanism in cultured skeletal muscle cells. Pathobiology 2007;74:159-168.
25. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004;164:1007-1019.
26. Foster W, Li Y, Usas A, Somogyi G, Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthopaed Res 2003;21:798-804.
27. Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, et al. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem 2007;282:25852-25863.
28. Bates SJ, Morrow E, Zhang AY, Pham H, Longaker MT, Chang J. Mannose-6-phosphate, an inhibitor of transforming growth factor-beta, improves range of motion after flexor tendon repair. J Bone Joint Surg Am 2006;88:2465-2472.
29. Chan Y-S, Li Y, Foster W, Fu FH, Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 2005;33:43-51.
30. Zhu J, Li Y, Lu A, Gharaibeh B, Ma J, Kobayashi T, et al. Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol 2011;179:915-930.
31. Bondesen BA, Mills ST, Kegley KM, Pavlath GK. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 2004;287:C475-483.
32. Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol 2006;290:C1651-1659.
33. Gharaibeh B, Chun-Lansinger Y, Hagen T, Ingham SJ, Wright V, Fu F, et al. Biological approaches to improve skeletal muscle healing after injury and disease. Birth Defects Res C Embryo Today 2012;96:82-94.
34. Cencic J, Langerholc T, Trapecar M, Gradisnik L, Cencic A. Novel muscle cell assay for applications in biomedicine. In: Abstracts (Current medicinal chemistry). Schiphol: Bentham; 2012. 135-136 p.
35. Cencic J, Cencic A. Applications of muscle cell assay. In: 7th Annual Congress of International Drug Discovery in Science and Technology. Shanghai, China, 2009, p 599.
36. Nagamine K, Kawashima T, Ishibashi T, Kaji H, Kanzaki M, Nishizawa M. Micropatterning contractile C(2)C(12) myotubes embedded in a fibrin gel. Biotechnol Bioeng 2010;105:1161-1167.
37. Shimizu K, Fujita H, Nagamori E. Alignment of skeletal muscle myoblasts and myotubes using linear micropatterned surfaces ground with abrasives. Biotechnol Bioeng 2009;103:631-638.
38. Tourovskaia A, Figueroa-Masot X, Folch A. Long-term microfluidic cultures of myotube microarrays for high-throughput focal stimulation. Nat Protoc 2006;1:1092-1104.
39. Zhao Y, Zeng HS, Nam J, Agarwal S. Fabrication of skeletal muscle constructs by topographic activation of cell alignment. Biotechnol Bioeng 2009;102:624-631.
40. Engler AJ, Griffin MA, Sen S, Bonnetnann CG, Sweeney HL, Discher DE. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 2004;166:877-887.
41. Griffin MA, Sen S, Sweeney HL, Discher DE. Adhesion-contractile balance in myocyte differentiation. J Cell Sci 2004;117:5855-5863.
42. Bian WN, Bursac N. Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials 2009;30:1401-1412.
43. Matsumoto T, Sasaki JI, Alsberg E, Egusa H, Yatani H, Sohmura T. Three-dimensional cell and tissue patterning in a strained fibrin gel system. PloS One 2007;2.
44. Ghaemmaghami AM, Hancock MJ, Harrington H, Kaji H, Khademhosseini A. Biomimetic tissues on a chip for drug discovery. Drug Discov Today 2012;17:173-181.
45. Tourovskaia A, Li NZ, Folch A. Localized acetylcholine receptor clustering dynamics in response to microfluidic focal stimulation with agrin. Biophys J 2008;95:3009-3016.
46. Nagamine K, Kawashima T, Sekine S, Ido Y, Kanzaki M, Nishizawa M. Spatiotemporally controlled contraction of micropatterned skeletal muscle cells on a hydrogel sheet. Lab Chip 2011;11:513-517.
47. Chai H, Guo L, Wang X, Gao X, Liu K, Fu Y, et al. In vitro and in vivo evaluations on osteogenesis and biodegradability of a β-tricalcium phosphate coated magnesium alloy. J Biomed Mater Res A 2012;100:293-304.
48. Allen M, Myer B, Rushton N. In vitro and in vivo investigations into the biocompatibility of diamond-like carbon (DLC) coatings for orthopedic applications. J Biomed Mater Res 2001;58:319-328.
49. Chen J-C, Ko C-L, Shih C-J, Tien Y-C, Chen W-C. Calcium phosphate bone cement with 10wt% platelet-rich plasma in vitro and in vivo. J Dent 2011;40:112-122.
50. Wang X, Qiu Y, Triffitt J, Carr A, Xia Z, Sabokbar A. Proliferation and differentiation of human tenocytes in response to platelet rich plasma: an in vitro and in vivo study. J Orthop Res Soc 2011;30:982-990.
51. Ishida K, Kuroda R, Miwa M, Tabata Y, Hokugo A, Kawamoto T, et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng 2007;13:1103-1112.
52. Bedair HS, Karthikeyan T, Quintero A, Li Y, Huard J. Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med 2008;36:1548-1554.
53. Larson-Meyer DE, Newcomer BR, Hunter GR, Joanisse DR, Weinsier RL, Bamman MM. Relation between in vivo and in vitro measurements of skeletal muscle oxidative metabolism. Muscle Nerve 2001;24:1665-1676.
54. Shemyakin A, Salehzadeh F, Esteves Duque-Guimaraes D, Bohm F, Rullman E, Gustafsson T, et al. Endothelin-1 reduces glucose uptake in human skeletal muscle in vivo and in vitro. Diabetes 2011;60:2061-2067.